A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma.
about
Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.Systemic therapies for hepatocellular carcinoma.Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma.Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies.MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?
P2860
A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A multi-centre randomized phas ...... nced hepatocellular carcinoma.
@ast
A multi-centre randomized phas ...... nced hepatocellular carcinoma.
@en
A multi-centre randomized phas ...... nced hepatocellular carcinoma.
@nl
type
label
A multi-centre randomized phas ...... nced hepatocellular carcinoma.
@ast
A multi-centre randomized phas ...... nced hepatocellular carcinoma.
@en
A multi-centre randomized phas ...... nced hepatocellular carcinoma.
@nl
prefLabel
A multi-centre randomized phas ...... nced hepatocellular carcinoma.
@ast
A multi-centre randomized phas ...... nced hepatocellular carcinoma.
@en
A multi-centre randomized phas ...... nced hepatocellular carcinoma.
@nl
P2093
P356
P1476
A multi-centre randomized phas ...... nced hepatocellular carcinoma.
@en
P2093
Johnston A
P2888
P304
P356
10.1007/S002800050982
P577
1999-01-01T00:00:00Z
P6179
1012779448